Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?

BARD1 mutation prostate cancer risk survival

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
30 Oct 2021
Historique:
received: 11 10 2021
revised: 26 10 2021
accepted: 28 10 2021
entrez: 13 11 2021
pubmed: 14 11 2021
medline: 14 11 2021
Statut: epublish

Résumé

The current cancer testing gene panels tend to be comprehensive rather than site-specific.

Identifiants

pubmed: 34771627
pii: cancers13215464
doi: 10.3390/cancers13215464
pmc: PMC8582358
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Science Centre Poland
ID : 2015/19/B/NZ2/02439

Références

Oncol Rep. 2015 Nov;34(5):2609-17
pubmed: 26329992
JCO Precis Oncol. 2019 Sep 17;3:
pubmed: 32923857
N Engl J Med. 2021 Feb 4;384(5):428-439
pubmed: 33471991
Nat Genet. 2015 Jun;47(6):643-6
pubmed: 25915596
Genes (Basel). 2020 Jul 27;11(8):
pubmed: 32726901
Genet Med. 2015 Feb;17(2):131-42
pubmed: 25058500
N Engl J Med. 1997 May 15;336(20):1401-8
pubmed: 9145676
Oncotarget. 2020 Jan 28;11(4):440-442
pubmed: 32064047
J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65
pubmed: 12237281
J Clin Oncol. 2013 May 10;31(14):1713-8
pubmed: 23530095
Oncotarget. 2017 Feb 7;8(6):9339-9353
pubmed: 28030839
Eur Urol. 2017 May;71(5):740-747
pubmed: 27989354
N Engl J Med. 2012 Jan 12;366(2):141-9
pubmed: 22236224
JAMA. 2016 Jan 5;315(1):68-76
pubmed: 26746459
Nature. 2017 Oct 19;550(7676):360-365
pubmed: 28976962
Genes (Basel). 2017 Dec 08;8(12):
pubmed: 29292755
Eur Urol. 2019 Sep;76(3):329-337
pubmed: 30777372
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Am J Hum Genet. 2003 Feb;72(2):270-80
pubmed: 12533788
Br J Cancer. 2021 Aug;125(4):569-575
pubmed: 34006922
Nat Genet. 2013 Mar;45(3):279-84
pubmed: 23334666
Oncogene. 2005 May 26;24(23):3726-36
pubmed: 15782130
Cancer Res. 2004 Feb 15;64(4):1215-9
pubmed: 14973119
Nat Genet. 2021 Jan;53(1):65-75
pubmed: 33398198
JAMA Oncol. 2017 Sep 1;3(9):1190-1196
pubmed: 28418444
PLoS Genet. 2019 Mar 29;15(3):e1008049
pubmed: 30925164
Sci Rep. 2015 May 21;5:10424
pubmed: 25994375
Eur Urol. 2020 Jan;77(1):24-35
pubmed: 31495749
Br J Cancer. 2013 Feb 5;108(2):461-8
pubmed: 23149842
Nat Genet. 1996 Dec;14(4):430-40
pubmed: 8944023
Int J Cancer. 2020 Nov 15;147(10):2793-2800
pubmed: 32875559
Nat Genet. 2009 Jun;41(6):718-23
pubmed: 19412175
Cancers (Basel). 2019 May 28;11(6):
pubmed: 31142030
J Clin Oncol. 2020 Aug 20;38(24):2798-2811
pubmed: 32516092
Br J Cancer. 2012 May 8;106(10):1697-701
pubmed: 22516946
Nat Genet. 2018 Jul;50(7):928-936
pubmed: 29892016
Mol Cell. 2001 Dec;8(6):1255-66
pubmed: 11779501
Genes (Basel). 2020 Jul 15;11(7):
pubmed: 32679805
J Natl Cancer Inst. 2021 May 4;113(5):616-625
pubmed: 32853339
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3367-71
pubmed: 1565627
N Engl J Med. 2016 Aug 4;375(5):443-53
pubmed: 27433846
Int J Biochem Cell Biol. 2016 Mar;72:1-17
pubmed: 26738429
Cancers (Basel). 2019 Oct 13;11(10):
pubmed: 31614901

Auteurs

Klaudia Stempa (K)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Dominika Wokołorczyk (D)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Wojciech Kluźniak (W)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Emilia Rogoża-Janiszewska (E)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Karolina Malińska (K)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Helena Rudnicka (H)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Tomasz Huzarski (T)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Department of Clinical Genetics and Pathology, University of Zielona Góra, 65-417 Zielona Góra, Poland.

Jacek Gronwald (J)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Katarzyna Gliniewicz (K)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Tadeusz Dębniak (T)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Anna Jakubowska (A)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Marcin Lener (M)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Joanna Tomiczek-Szwiec (J)

Department of Histology, Department of Biology and Genetics, Faculty of Medicine, University of Opole, 45-040 Opole, Poland.

Paweł Domagała (P)

Department of Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Malwina Suszynska (M)

Department of Molecular Genetics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland.

Piotr Kozlowski (P)

Department of Molecular Genetics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland.

Tomasz Kluz (T)

Department of Gynecology and Obstetrics, Institute of Medical, Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.

Mariusz Naczk (M)

Collegium Medicum, University of Zielona Gora, 65-417 Zielona Gora, Poland.

Jan Lubiński (J)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Steven A Narod (SA)

Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON M5G 1N8, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada.

Mohammad R Akbari (MR)

Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON M5G 1N8, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada.

Cezary Cybulski (C)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.

Classifications MeSH